Table 1.
Characteristics of reference sample groups by location
Figure 1.
Hemoglobin intervals and medians by site and gender (men: blue, women: white) including U.S.-based comparison interval and cutoff for DAIDS grade one severity (vertical dashed line).
Table 2.
Hematology results, U.S.-based comparison intervals and out of range (OOR) values
Figure 2.
Neutrophil intervals and medians by site and gender (men: blue, women: white) including U.S.-based comparison interval and cutoff for DAIDS grade one severity (vertical dashed line).
Figure 3.
Eosinophil count intervals and medians by site and gender (men: blue, women: white) including U.S.-based comparison interval.
Figure 4.
CD4 count intervals and medians by site and gender (men: blue, women: white) including U.S.-based comparison interval and cutoff for DAIDS grade one severity (vertical dashed line).
Figure 5.
Total bilirubin intervals and medians by site and gender (men: blue, women: white) including U.S.-based comparison interval and cutoff for DAIDS grade one severity (vertical dashed line).
Figure 6.
Direct bilirubin intervals and medians by site and gender (men: blue, women: white) including U.S.-based comparison interval.
Table 3.
Chemistry results, U.S.-based comparison intervals, and out of range (OOR) values
Figure 7.
IgG intervals and medians by site and gender (men: blue, women: white) including U.S.-based comparison interval.
Figure 8.
LDH intervals and medians by site and gender (men: blue, women: white) including U.S.-based comparison interval.
Table 4.
Analyte results and frequency of “adverse events” graded against western-derived DAIDS AE cutoffs*